Long-acting Injectable Cabotegravir for PrEP Is Promising Long-acting Injectable Cabotegravir for PrEP Is Promising

Dr Paul Sax discusses the interim results from a study on the use of the long-acting injectable cabotegravir for pre-exposure prophylaxis in cisgender men and transgender women who have sex with men.Medscape HIV/AIDS
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS Commentary Source Type: news